Skip to main content
. 2022 Jan 20;14(2):241. doi: 10.3390/pharmaceutics14020241

Table 14.

EGFR-targeted PDT performed with an anti-EGFR aptamer.

Targeting Agent PS In Vitro Studies In Vivo Studies Ref.
anti-EGFR DNA R13 aptamer 5′-TTT ATG GGT GGG TGG GGG GTT TTT; S14, 5′-GAT TGT CCC CGC GCC TGG TTG AAG Trimalonic acid-modified C70 fullerene (TF70) A549 [238]